Dileema Kalansuriya

Dileema Kalansuriya practices at Nuvance Health Medical Practice CT, Inc. in Danbury, Connecticut.

Dileema Kalansuriya's NPI, 1972785608, was assigned on December 5, 2007. Dileema Kalansuriya graduated from University of Colombo Faculty of Medicine in 2002. Dileema Kalansuriya holds Connecticut license 1563394K73.

Dileema Kalansuriya's primary practice is Nuvance Health Medical Practice CT, Inc., at 100 Reserve Rd, Danbury, CT 06810 in Western Ct County. The practice phone is (203) 739-7742.

Dileema Kalansuriya's primary practice is Nuvance Health Medical Practice CT, Inc. in Danbury, Connecticut. Dileema Kalansuriya is also affiliated with Northwell Danbury Hospital. The medical group on file is Danbury Medical Group. Dmand AI also links Dileema Kalansuriya to 1 more hospital, 5 home health agencies, 2 medical groups, 1 group practice or clinic and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dileema Kalansuriya practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dileema Kalansuriya's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dileema Kalansuriya is licensed in Connecticut.

CMS data shows 1,816 Medicare services from Dileema Kalansuriya across 20 procedure codes in 2024, for 449 Medicare patients. Medicare paid $149,377 for them. Every service was in an office.

CMS counts 449 Medicare patients who saw Dileema Kalansuriya in 2024. The largest group is 75 to 84, with 175 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dileema Kalansuriya's median patient age at 67, with 72% women.

In 2024, Dileema Kalansuriya wrote 8,084 Medicare Part D claims for 892 patients. 86% of them were for generic drugs. CMS names the drug for 7,286 of them, across 119 drugs with 11 or more claims each, at $723,205 in total drug cost. In 2023, CMS named 7,432 claims across 127 drugs.

Dileema Kalansuriya accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dileema Kalansuriya as offering telehealth.

CMS Open Payments shows 24 general payments to Dileema Kalansuriya from 13 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 90% of the total. AstraZeneca Pharmaceuticals LP paid the most, $77.

Dileema Kalansuriya graduated from University of Colombo Faculty of Medicine in 2002.